Playback speed
10 seconds
KU ASCO 2019 Non Hodgkin Lymphoma Update : Polatuzumab Vedotin for R/R DLBCL, Chemo for Waldenstroms, Lenalidomide and Rituximab in Relapsed Indolent Lymphoma, & Induction Rituximab in iNHL
450 views
August 19, 2019
Login to view comments.
Click here to Login